AU4165699A - Composition for treating cartilage disease - Google Patents
Composition for treating cartilage diseaseInfo
- Publication number
- AU4165699A AU4165699A AU41656/99A AU4165699A AU4165699A AU 4165699 A AU4165699 A AU 4165699A AU 41656/99 A AU41656/99 A AU 41656/99A AU 4165699 A AU4165699 A AU 4165699A AU 4165699 A AU4165699 A AU 4165699A
- Authority
- AU
- Australia
- Prior art keywords
- composition
- cartilage disease
- treating cartilage
- treating
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10/167507 | 1998-06-15 | ||
JP16750798 | 1998-06-15 | ||
PCT/JP1999/003154 WO1999065474A2 (en) | 1998-06-15 | 1999-06-14 | Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4165699A true AU4165699A (en) | 2000-01-05 |
Family
ID=15850970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU41656/99A Abandoned AU4165699A (en) | 1998-06-15 | 1999-06-14 | Composition for treating cartilage disease |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1087774A2 (en) |
AR (1) | AR019664A1 (en) |
AU (1) | AU4165699A (en) |
CA (1) | CA2334815A1 (en) |
WO (1) | WO1999065474A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1103552A4 (en) | 1998-08-07 | 2003-01-15 | Takeda Chemical Industries Ltd | Benzothiepin derivatives, process for the preparation of the same and uses thereof |
WO2001066142A1 (en) * | 2000-03-10 | 2001-09-13 | Chugai Seiyaku Kabushiki Kaisha | Preparations for chondrogenesis |
WO2001089521A1 (en) * | 2000-05-23 | 2001-11-29 | Takeda Chemical Industries, Ltd. | Medicinal compositions containing thiophene derivatives |
FI129515B (en) | 2020-11-06 | 2022-03-31 | Salarusta Oy | Hica for use in prophylaxis and/or treatment of a disease or condition involving degradation of cartilage and/or disruption of cartilage homeostasis and/or integrity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ231939A (en) * | 1988-12-28 | 1991-07-26 | Takeda Chemical Industries Ltd | Benzothiopyran derivatives and medicaments |
ATE203020T1 (en) * | 1990-05-30 | 2001-07-15 | Takeda Chemical Industries Ltd | SULFUR CONTAINING HETEROCYCLIC COMPOUNDS |
TW403757B (en) * | 1994-12-28 | 2000-09-01 | Takeda Chemical Industries Ltd | Optically active benzothiepin derivative, its preparation and use |
AU717260B2 (en) * | 1995-06-05 | 2000-03-23 | Takeda Chemical Industries Ltd. | Osteogenetic promoting pharmaceutical composition |
ATE226078T1 (en) * | 1996-08-26 | 2002-11-15 | Takeda Chemical Industries Ltd | PHARMACEUTICAL COMPOSITION CONTAINING AN OSTEOGENESIS PROMOTING AGENT AND A POLYETHYLENE GLYCOL |
-
1999
- 1999-06-14 WO PCT/JP1999/003154 patent/WO1999065474A2/en not_active Application Discontinuation
- 1999-06-14 EP EP99925310A patent/EP1087774A2/en not_active Withdrawn
- 1999-06-14 AU AU41656/99A patent/AU4165699A/en not_active Abandoned
- 1999-06-14 CA CA002334815A patent/CA2334815A1/en not_active Abandoned
- 1999-06-15 AR ARP990102842 patent/AR019664A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999065474A3 (en) | 2000-04-06 |
CA2334815A1 (en) | 1999-12-23 |
EP1087774A2 (en) | 2001-04-04 |
WO1999065474A2 (en) | 1999-12-23 |
AR019664A1 (en) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3085599A (en) | Bone cement compositions | |
AU7582398A (en) | Composition for treating skin conditions | |
AU2111500A (en) | Bone tissue regenerating composition | |
GB9809058D0 (en) | Composition | |
AU1809600A (en) | Anti-snoring composition | |
GB9812119D0 (en) | Composition | |
AU3242299A (en) | Waste treatment system | |
AU7432698A (en) | Disinfectant composition | |
GB9827894D0 (en) | Composition | |
GB9806793D0 (en) | Composition | |
AU4165699A (en) | Composition for treating cartilage disease | |
GB9914796D0 (en) | Composition | |
AU6966998A (en) | Composition for treating pain | |
AU3455000A (en) | Composition for decomposing protein | |
GB9903310D0 (en) | Composition | |
AU7247898A (en) | Composition for treating pain | |
AU2016199A (en) | Peptide mimics useful for treating disease | |
GB9804041D0 (en) | Composition | |
AU1787999A (en) | Bone material | |
AU4993000A (en) | Waste treatment composition | |
AU2648899A (en) | Composition | |
AU5314999A (en) | Modified oligonucleotides | |
AU8386098A (en) | Orthopedic supports | |
AU4521599A (en) | Germicidal composition | |
AU5524399A (en) | Inorgasmia treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |